Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

N/ACompletedNCT01903213

Astellas Pharma Inc123 enrolled

Overview

To evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.

Study Type

OBSERVATIONAL

Enrollment

123

Oral

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Chronic renal failure patients with Hyperphosphatemia receiving peritoneal dialysis

Unnamed facility

Chugoku, Japan

Unnamed facility

Chūbu, Japan

Unnamed facility

Hokkaido, Japan

Unnamed facility

Kansai, Japan

Unnamed facility

Kanto, Japan

Safety assessed by the incidence of adverse events (including adverse drug reactions), vital signs and laboratory tests